Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

Summary

The purpose of the trial is to investigate the efficacy of combining tolterodine and desmopressin compared with tolterodine monotherapy in the treatment of women with overactive bladder with nocturia in terms of reduction of nocturnal voids during 3 months of treatment

Timeline

Start

2013-01

Primary completion

2014-11

Completion

2014-11

Outcome

Missed primary endpoint

registry analysis (superiority test); Combination vs Tolterodine; p = 0.112; Mean Difference (Final Values) -0.34 (95% CI -0.77 to 0.08); ANCOVA NCT01729819 ↗

Drugs

Indications